Houcine Rahali
9Patents
3h-index
49Co-inventors
53Inventor score
Filing activity: Jun 30, 2006 → Aug 5, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8362068B2 | 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors | Chemistry; Metallurgy | 44 | Active |
| US9296778B2 | 3′,5′-cyclic phosphate prodrugs for HCV infection | Chemistry; Metallurgy | 18 | Active |
| US10519159B2 | Antiviral aliphatic ester prodrugs of tenofovir | Emerging Cross-Sectional Technologies | 4 | Active |
| US8426437B2 | Pyrroloquinoline derivatives and their use as protein kinases inhibitors | Human Necessities | 3 | Active |
| US10449208B2 | Antiviral prodrugs of tenofovir | Human Necessities | 3 | Active |
| US12173026B2 | PRMT5 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10736908B2 | Antiviral aryl-amide phosphodiamide compounds | Chemistry; Metallurgy | 0 | Active |
| US9187496B2 | 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10513534B2 | 2′-chloro nucleoside analogs for HCV infection | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.